AstraZeneca
AZN
AZN
386 hedge funds and large institutions have $7.88B invested in AstraZeneca in 2014 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 105 increasing their positions, 167 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
1.79% less ownership
Funds ownership: 20.87% → 19.08% (-1.8%)
37% less repeat investments, than reductions
Existing positions increased: 105 | Existing positions reduced: 167
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
Holders
386
Holding in Top 10
5
Calls
$181M
Puts
$92.5M
Top Buyers
| 1 | +$233M | |
| 2 | +$128M | |
| 3 | +$73.5M | |
| 4 |
AG
Aperio Group
Sausalito,
California
|
+$26.3M |
| 5 |
Millennium Management
New York
|
+$22.6M |
Top Sellers
| 1 | -$219M | |
| 2 | -$111M | |
| 3 | -$89.4M | |
| 4 |
Renaissance Technologies
New York
|
-$83.5M |
| 5 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$75.9M |